Empirical therapy for hepatic lesions in suspected clonorchiasis: a comparative efficacy analysis of Albendazole and Praziquantel
Frontiers in Pharmacology · 08.07.2026 · 17
DOI: 10.3389/fphar.2026.1878617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 08.07.2026. Verfasst von Ya-Zhao Cao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Clonorchiasis frequently presents as intrahepatic space-occupying lesions, posing a diagnostic challenge due to the low sensitivity of fecal examination. While Praziquantel is the standard first-line therapy, Albendazole is often used empirically in suspected cases. However, the comparative efficacy of these two agents across different levels of diagnostic certainty (confirmed vs. suspected) remains poorly defined.
Methods
This retrospective cohort study included 151 patients with clonorchiasis-related hepatic lesions treated at our institution between January 2018 and December 2025. Patients were categorized into a Praziquantel group ( n = 78) and an Albendazole group ( n = 73). The primary outcome was clinical cure within 90 days, defined as symptom resolution, lesion reduction ≥50%, and normalization of eosinophil counts. Multivariable logistic regression and Generalized Estimating Equations (GEE) were employed to evaluate the interaction between treatment regimens and diagnostic certainty.
Results
The overall clinical cure rate was higher in the Praziquantel group (76.9%, 60/78) than in the Albendazole group (67.1%, 49/73), though the difference was not statistically significant ( χ 2 = 1.804, P = 0.179). Stratified analysis revealed that Praziquantel was significantly more effective in confirmed cases (90.0% vs. 62.5%, P = 0.047), whereas no significant difference was observed in suspected cases (68.8% vs. 68.4%, P = 0.971). The “Drug/times Diagnosis” interaction test showed marginal significance ( P = 0.064). After adjusting for confounders, Albendazole showed similar clinical outcomes to Praziquantel (Adjusted OR = 0.665, 95% CI: 0.298–1.482, P = 0.318). GEE analysis confirmed a significant “Drug × Time” interaction ( P < 0.001), indicating distinct kinetic patterns of recovery, with Praziquantel demonstrating a superior cure advantage over time. Age was identified as an independent predictor of clinical cure ( P = 0.017).
Conclusion
The efficacy of Albendazole in treating clonorchiasis-related hepatic lesions is modulated by diagnostic certainty. While Praziquantel remains the superior choice for confirmed cases, Albendazole demonstrates comparable clinical efficacy in stool-negative suspected cases. These findings indicate that Albendazole demonstrates similar lesion resolution to Praziquantel in stool-negative suspected cases. However, given the retrospective design, these results should be interpreted as hypothesis-generating, necessitating prospective trials for confirmation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
- Department of Internal Medicine II, Guangzhou Guanggang New Town Hospital, Guangzhou, Guangdong, China.
- Department of Infectious Diseases, Guangzhou Panyu Maternal and Child Health Care Hospital, Guangzhou, Guangdong, China.
Zitieren
APA
Cao, Y. Z., Guo, P. Z., Zhang, Y. F., Li, W. Y., Shen, Q. F., Li, Z. H., Lei, Z. Y., Chen, J. F., & Zhang, J. (2026). Empirical therapy for hepatic lesions in suspected clonorchiasis: a comparative efficacy analysis of Albendazole and Praziquantel. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1878617
Vancouver
Cao YZ, Guo PZ, Zhang YF, Li WY, Shen QF, Li ZH, et al. Empirical therapy for hepatic lesions in suspected clonorchiasis: a comparative efficacy analysis of Albendazole and Praziquantel. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1878617
BibTeX
@article{Cao2026,
author = {Cao, Ya-Zhao and Guo, Peng-Zhen and Zhang, Yu-Feng and Li, Wen-Yu and Shen, Qi-Fa and Li, Zhi-Hui and Lei, Zi-Ying and Chen, Jun-Feng and Zhang, Jing},
title = {Empirical therapy for hepatic lesions in suspected clonorchiasis: a comparative efficacy analysis of Albendazole and Praziquantel},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1878617}
}
EUVIMED